Cargando…

Optical Coherence Tomography Angiography Is a Useful Tool for Distinguishing Primary Raynaud’s Phenomenon from Systemic Sclerosis and/or Very Early Disease of Systemic Sclerosis

This cross-sectional study aimed to compare optical coherence tomography angiography (OCT-A) findings in patients with primary Raynaud’s phenomenon (PRP; n = 22), very early disease of systemic sclerosis (VEDOSS; n = 19), and systemic sclerosis (SSc; 25 patients with limited cutaneous SSc (lcSSc) an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Erturk, Adem, Erogul, Ozgur, Kasikci, Murat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417700/ https://www.ncbi.nlm.nih.gov/pubmed/37568970 http://dx.doi.org/10.3390/diagnostics13152607

Ejemplares similares

Raynaud’s Phenomenon with Focus on Systemic Sclerosis
por: Maciejewska, Magdalena, et al.
Publicado: (2022)

Audiovestibular Manifestations in Patients with Primary Raynaud’s Phenomenon and Raynaud’s Phenomenon Secondary to Systemic Sclerosis
por: Amor-Dorado, Juan Carlos, et al.
Publicado: (2023)

Hyperspectral imaging in systemic sclerosis-associated Raynaud phenomenon
por: Teaw, Shannon, et al.
Publicado: (2023)

The frequency of Raynaud’s phenomenon, very early diagnosis of systemic sclerosis, and systemic sclerosis in a large Veteran Health Administration database
por: Frech, Tracy M., et al.
Publicado: (2021)

Reduced levels of S-nitrosothiols in plasma of patients with systemic sclerosis and Raynaud's phenomenon
por: Kundu, Devi, et al.
Publicado: (2014)

Altered ocular microvasculature in patients with systemic sclerosis and very early disease of systemic sclerosis using optical coherence tomography angiography
por: Mihailovic, Nataša, et al.
Publicado: (2022)

Botulinum toxin in the treatment of Raynaud phenomenon in patients with systemic sclerosis: a systemic review
por: Cai, Ruyi, et al.
Publicado: (2022)

Endothelin Receptor Antagonists for the Treatment of Raynaud's Phenomenon and Digital Ulcers in Systemic Sclerosis
por: Arefiev, Kait, et al.
Publicado: (2011)

Rheopheresis for Digital Ulcers and Raynaud's Phenomenon in Systemic Sclerosis Refractory to Conventional Treatments
por: Korsten, Peter, et al.
Publicado: (2019)

Optical Coherence Tomography and Optical Coherence Tomography with Angiography in Multiple Sclerosis
por: Chalkias, Ioannis-Nikolaos, et al.
Publicado: (2022)

Application of the 2013 ACR/EULAR classification criteria for systemic sclerosis to patients with Raynaud’s phenomenon
por: Park, Jin-Su, et al.
Publicado: (2015)

Artifactual Hypoglycaemia in Systemic Sclerosis and Raynaud's Phenomenon: A Clinical Case Report and Short Review
por: Bishay, RH, et al.
Publicado: (2016)

Association between systemic sclerosis, palmar fasciitis with polyarthritis, Raynaud’s phenomenon and erythromelalgia with underlying malignancy
por: Nowak, Katarzyna, et al.
Publicado: (2022)

Systemic lupus erythematosus and Raynaud's phenomenon
por: Heimovski, Flavia Emilie, et al.
Publicado: (2015)

The Relationship between Smoking, Raynaud's Phenomenon, Digital Ulcers, and Skin Thickness in the Waikato Systemic Sclerosis Cohort
por: Silva, Cherumi, et al.
Publicado: (2022)

Efficacy of botulinum toxin type A injection for Raynaud’s phenomenon and digital ulcers in patients with systemic sclerosis
por: Jokar, Mohammad Hassan, et al.
Publicado: (2022)

Raynaud’s phenomenon
por: Solomons, HD
Publicado: (2011)

Raynaud's Phenomenon
por: Shah, Jehan, et al.
Publicado: (2013)

Angiography with optical coherence tomography as a biomarker in multiple sclerosis
por: Cordon, Beatriz, et al.
Publicado: (2020)

Optical Coherence Tomography and Optical Coherence Tomography Angiography Findings After Optic Neuritis in Multiple Sclerosis
por: Murphy, Olwen C., et al.
Publicado: (2020)

Progressive Systemic Sclerosis With Negative Antinuclear Antibodies and Absence of Raynaud’s Phenomenon: A Case Report and Literature Review
por: Falls, Anna C, et al.
Publicado: (2023)

Evaluation of optical coherence tomography angiography findings in patients with multiple sclerosis
por: Khader, Sarah A, et al.
Publicado: (2021)

In systemic sclerosis patients the anxiety disorder and Raynaud’s phenomenon are increased during lock down period for COVID-19 pandemic
por: Gigante, Antonietta, et al.
Publicado: (2020)

The effect of silver fibre gloves on Raynaud’s phenomenon in patients with systemic sclerosis: a double-blind randomized crossover trial
por: Liem, Sophie I E, et al.
Publicado: (2022)

Raynaud’s phenomenon in childhood-onset systemic lupus erythematous
por: Jiang, Qi, et al.
Publicado: (2022)

Optical coherence tomography angiography in multiple sclerosis: A cross-sectional study
por: Farci, Roberta, et al.
Publicado: (2020)

Efficacy and Safety of Selexipag in Adults With Raynaud's Phenomenon Secondary to Systemic Sclerosis: A Randomized, Placebo‐Controlled, Phase II Study
por: Denton, Christopher P., et al.
Publicado: (2017)

Self-Reported Systemic Sclerosis-Related Symptoms Are More Prevalent in Subjects with Raynaud’s Phenomenon in the Lifelines Population: Focus on Pulmonary Complications
por: van de Zande, Saskia Corine, et al.
Publicado: (2023)

Impacts of protective face masks on ocular surface symptoms among healthcare professionals during the COVID-19 pandemic
por: Erogul, Ozgur, et al.
Publicado: (2022)

Correction to: Impacts of protective face masks on ocular surface symptoms among healthcare professionals during the COVID‑19 pandemic
por: Erogul, Ozgur, et al.
Publicado: (2022)

Aptamer proteomics of serum exosomes from patients with Primary Raynaud’s and patients with Raynaud’s at risk of evolving into Systemic Sclerosis
por: Piera-Velazquez, Sonsoles, et al.
Publicado: (2022)

Advances in the treatment of Raynaud’s phenomenon
por: Levien, Terri L
Publicado: (2010)

Raynaud's phenomenon in pediatric age
por: Tavares, M, et al.
Publicado: (2011)

Raynaud's Phenomenon: Beware of Cancers!
por: Aqodad, Zahida, et al.
Publicado: (2021)

Solvent-Induced Raynaud’s Phenomenon
por: Rodrigues, Helena, et al.
Publicado: (2023)

Optical coherence tomography angiography helps distinguish multiple sclerosis from AQP4‐IgG‐seropositive neuromyelitis optica spectrum disorder
por: Liu, Chunxin, et al.
Publicado: (2021)

Optical Coherence Tomography Angiography (OCTA) in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder
por: Kleerekooper, Iris, et al.
Publicado: (2020)

Quantifying contact lens-related changes in keratoconus corneal topographic indices: an updated Pentacam Scheimpflug imaging analysis
por: Kasıkcı, Murat, et al.
Publicado: (2022)

Optical coherence tomography evaluation of pulmonary arterial vasculopathy in Systemic Sclerosis
por: Schwaiger, Johannes P., et al.
Publicado: (2017)

Evidence and consensus-based recommendations for non-pharmacological treatment of fatigue, hand function loss, Raynaud’s phenomenon and digital ulcers in patients with systemic sclerosis
por: Stöcker, Juliane K, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m4fmlekbdduh13erd4f0oog0g4